Huntington Beach, CALIFORNIA3 Active Studies

Diabetic Retinopathy Clinical Trials in Huntington Beach, CALIFORNIA

Find 3 actively recruiting diabetic retinopathy clinical trials in Huntington Beach, CALIFORNIA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
888
Enrolling

Recruiting Diabetic Retinopathy Studies in Huntington Beach

About Diabetic Retinopathy Clinical Trials in Huntington Beach

Diabetic retinopathy is a diabetes complication that affects the blood vessels in the retina and is the leading cause of blindness in working-age adults. Diabetic macular edema (DME) involves fluid accumulation in the macula. Treatment includes anti-VEGF injections, laser therapy, and blood sugar control.

There are currently 3 diabetic retinopathy clinical trials recruiting participants in Huntington Beach, CALIFORNIA. These studies are seeking a combined 888 participants. Research is being sponsored by Jaeb Center for Health Research, Boehringer Ingelheim, Kyowa Kirin Co., Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Diabetic Retinopathy Clinical Trials in Huntington Beach — FAQ

Are there diabetic retinopathy clinical trials in Huntington Beach?

Yes, there are 3 diabetic retinopathy clinical trials currently recruiting in Huntington Beach, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Huntington Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Huntington Beach research site will contact you about next steps.

Are clinical trials in Huntington Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Huntington Beach studies also compensate for your time and travel.

What diabetic retinopathy treatments are being tested?

The 3 active trials in Huntington Beach are testing new therapies including novel drugs, biologics, and treatment approaches for diabetic retinopathy.

Data updated March 2, 2026 from ClinicalTrials.gov